Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Open in API
Filings indexed 1,118 across all filing types
Latest filing 2023-07-14 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement from Unichem Laboratories Limited dated July 14, 2023, regarding the approval of unaudited financial results for the first quarter ended June 30, 2023. It includes comprehensive financial data such as revenue, expenses, profit/loss before and after tax, earnings per share, and notes explaining accounting policies and contingent liabilities. The presence of detailed financial statements and notes indicates this is a quarterly financial report. The document also mentions the review by the Audit Committee and Board approval, consistent with interim financial reporting requirements. The length of the document (15,000 characters) and the inclusion of substantive financial data confirm it is not merely an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2023-07-14 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 100% confidence The document is a detailed financial statement titled 'Statement of Standalone Unaudited Results for the Quarter ended 30th June, 2023' from Unichem Laboratories Limited. It includes comprehensive financial data such as revenue, expenses, profit/loss before tax, tax expenses, and earnings per share for the quarter ended June 30, 2023, along with comparative figures from previous quarters and the previous fiscal year. The document also contains notes explaining accounting policies, contingent liabilities, exceptional items, and auditor opinions. The presence of unaudited quarterly financial results, detailed financial tables, and management notes indicates this is a quarterly financial report. The document is not merely an announcement or a certification but contains substantive financial data and analysis for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2023-07-14 English
Unaudited Financial Results (Standalone & Consolidated ) for the quarter 30.6.2023 approved by the Board on 14.7.2023
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement from Unichem Laboratories Limited dated July 14, 2023, regarding the outcome of a Board Meeting where the Board approved the Unaudited Financial Results (Standalone & Consolidated) for the first quarter ended June 30, 2023. The document includes comprehensive financial data such as revenue, expenses, profit/loss before tax, tax expenses, and earnings per share for the quarter, along with notes explaining accounting policies and contingent liabilities. It also contains auditor's reports and qualified opinions related to the financial results. The presence of detailed financial statements and analysis for a quarter shorter than a full fiscal year, along with the unaudited status, clearly indicates this is an Interim / Quarterly Report. The document is lengthy (15,000 characters) and contains substantive financial data, not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2023-07-14 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-07-13 English
Compliance Certificate under Reg. 74(5) of (Depositories & Participants) Regulation, 2018 for the Quarter Ended June 30, 2023
Regulatory Filings
2023-07-13 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-07-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.